Robert L. Carithers, Jr., MD

Clinical research involving liver transplantation and the evaluation and management of patients with chronic hepatitis. Emphasis on the design and management of randomized control trials of new treatments for liver disease, and prognosis of patients prior to and following liver transplantation. Immunogenetics in response to chronic viral hepatosis.

Shuhart MC, Bronner MP, Gretch DR, Thomassen LV, Wartelle CF, Tateyama H et al, Histological and Clinical outcome after liver transplantation for hepatitis C. Hepatology 1997: 26(6); 1646-1652.

Carthers RL, Jr., Emerson SS, Therapy of hepatitis C: meta-analysis of interferon alfa-2b trials. Hepatology 1997; 26(3 Suppl 1):83S-88S.

Carithers RL Jr. AASLD Practice Guidelines: Liver transplantation. Liver Transpl 2000;6:122-135.

Carithers RL Jr, Marquardt A, Gretch DR. Diagnostic testing for hepatitis C. Semin Liver Dis 2000; 20:159-171.

Combes B, Carithers RL Jr, Maddrey WC, et al. A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1995;22:759-766.

Gretch DR, Bacchi CE, Corey L, dela RC, Lesniewski RR, Kowdley K et al. Persistent hepatitis C virus infection after liver transplantation: clinical and virological features. Hepatology 1995;22(1):1-9.